{"id":2257,"date":"2014-03-18T11:05:18","date_gmt":"2014-03-18T15:05:18","guid":{"rendered":"https:\/\/www.bu.edu\/amyloid\/?page_id=2257"},"modified":"2020-04-27T15:47:12","modified_gmt":"2020-04-27T19:47:12","slug":"_2013","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/amyloid\/research\/publications\/archive\/_2013\/","title":{"rendered":"2013"},"content":{"rendered":"<p><strong>Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, Heneghan MA, Gorevic PD, Litchy WJ, Wiesman JF, Nordh E, Corato M, Lozza A, Cortese A, Robinson-Papp J, Colton T, Rybin DV, Bisbee AB, Ando Y, Ikeda S, Seldin DC, Merlini G, Skinner M, Kelly JW, Dyck PJ.<\/strong>\u00a0 Diflunisal Trial Consortium.\u00a0 Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.\u00a0 <em>JAMA, <\/em>310(24):2658-67, 2013.\u00a0 View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24368466\" target=\"_blank\" jquery191040708974266252334=\"661\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><strong>Cowan AJ, Skinner M, Seldin DC, Berk JL, Lichtenstein DR, O&#8217; Hara CJ, Doros G, Sanchorawala V.<\/strong>\u00a0 Amyloidosis of the gastrointestinal tract: a 13-year single center referral experience. <em>Haematologica,<\/em> 98(1):141-146, 2013.\u00a0 View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22733017\" target=\"_blank\" jquery191040708974266252334=\"771\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span id=\"ctl00_rpPublication_ctl06_lblPublication\" jquery191017260350891606668=\"567\"><strong>Leung A, Nah SK, Reid W, Ebata A, Koch CM, Monti S, Genereux JC, Wiseman RL, Wolozin B, Connors LH, Berk JL, Seldin DC, Mostoslavsky G, Kotton DN, Murphy GJ.<\/strong>\u00a0 Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis.\u00a0 <em>Stem Cell Reports,<\/em>\u00a01(5):451-63, 2013.\u00a0 <\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24286032\" target=\"_blank\" jquery191017260350891606668=\"569\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><strong>Sanchorawala V, Patel JM, Sloan JM, Shelton AC, Zeldis JB, Seldin DC.<\/strong>\u00a0 Melphalan, lenalidomide and dexamethasone for the treatment of AL amyloidosis: results of a phase II trial.\u00a0 <em>Haematologica,<\/em>\u00a098 (5):789-792, 2013.\u00a0 View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23144200\" target=\"_blank\" jquery191040708974266252334=\"736\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span id=\"ctl00_rpPublication_ctl14_lblPublication\" jquery19109748968072175506=\"518\"><strong>Taimur S, Nader C, Lloyd-Travaglini C, Seldin DC, Sanchorawala V.<\/strong>\u00a0 Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis.\u00a0 <em>Transpl Infect Dis,<\/em>\u00a015(2):187-94, 2013.\u00a0 <\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23279695\" target=\"_blank\" jquery19109748968072175506=\"520\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span id=\"ctl00_rpPublication_ctl13_lblPublication\" jquery19109748968072175506=\"513\"><strong>Sarosiek S, Seldin DC, Berk JL, Sanchorawala V.<\/strong>\u00a0 A solitary mediastinal mass due to localized AL amyloidosis: case report and review of the literature.\u00a0 <em>Amyloid: J Prot Folding Disorders<\/em>, 20(2):127-30, 2013.\u00a0 <\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23461593\" target=\"_blank\" jquery19109748968072175506=\"515\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span id=\"ctl00_rpPublication_ctl07_lblPublication\" jquery19104281527696515696=\"530\"><strong>Ruberg FL, Miller EJ.<\/strong>\u00a0 Nuclear tracers for transthyretin cardiac amyloidosis: time to bone up?\u00a0 <em>Circ Cardiovasc Imaging,<\/em>\u00a06(2):162-4, 2013.\u00a0 <\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23512778\" target=\"_blank\" jquery19104281527696515696=\"532\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span id=\"ctl00_rpPublication_ctl12_lblPublication\" jquery19109748968072175506=\"508\"><strong>Sanchorawala V, Shelton AC, Zeldis JB, Seldin DC.<\/strong>\u00a0 Risk of second primary malignancy in patients with AL amyloidosis treated with lenalidomide.\u00a0 <em>Am J Hematol,<\/em>\u00a088(8):719, 2013.\u00a0 <\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23650113\" target=\"_blank\" jquery19109748968072175506=\"510\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span id=\"ctl00_rpPublication_ctl11_lblPublication\" jquery19109748968072175506=\"503\"><strong>Girnius S, Seldin DC, Cibeira MT, Sanchorawala V.<\/strong>\u00a0 New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation.\u00a0 <em>J Clin Oncol,<\/em>\u00a031(21):2749-50, 2013.\u00a0 <\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23775968\" target=\"_blank\" jquery19109748968072175506=\"505\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span id=\"ctl00_rpPublication_ctl10_lblPublication\" jquery19109748968072175506=\"498\"><strong>Sanchorawala V, Hoering A, Seldin DC, Finn KT, Fennessey SA, Sexton R, Mattar B, Safah HF, Holmberg LA, Dean RM, Orlowski RZ, Barlogie B.<\/strong>\u00a0 Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115.\u00a0 <em>Bone Marrow Transplant,<\/em>\u00a048(12):1537-42, 2013.\u00a0 <\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23852321\" target=\"_blank\" jquery19109748968072175506=\"500\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span><span id=\"ctl00_rpPublication_ctl10_lblPublication\" jquery191017260350891606668=\"587\"><strong>Tanaka K, Essick EE, Doros G, Tanriverdi K, Connors LH, Seldin DC, Sam F.<\/strong>\u00a0 Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.\u00a0 <em>J Am Heart Assoc,<\/em>\u00a02(2):e005868, 2013.\u00a0 <\/span><\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23537813\" target=\"_blank\" jquery191017260350891606668=\"589\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span><span id=\"ctl00_rpPublication_ctl09_lblPublication\" jquery191017260350891606668=\"582\"><strong>Mishra S, Guan J, Plovie E, Seldin DC, Connors LH, Merlini G, Falk RH, MacRae CA, Liao R.<\/strong>\u00a0 Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.\u00a0 <em>Am J Physiol Heart Circ Physiol,<\/em> 305(1):H95-103, 2013.\u00a0 <\/span><\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23624626\" target=\"_blank\" jquery191017260350891606668=\"584\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span><span id=\"ctl00_rpPublication_ctl08_lblPublication\" jquery191017260350891606668=\"577\"><strong>Guan J, Mishra S, Shi J, Plovie E, Qiu Y, Cao X, Gianni D, Jiang B, Del Monte F, Connors LH, Seldin DC, Lavatelli F, Rognoni P, Palladini G, Merlini G, Falk RH, Semigran MJ, Dec GW, Macrae CA, Liao R.<\/strong>\u00a0 Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity.\u00a0 <em>Basic Res Cardiol,<\/em>\u00a0108(5):378, 2013.\u00a0 <\/span><\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23982491\" target=\"_blank\" jquery191017260350891606668=\"579\" rel=\"noopener\">PubMed<\/a><\/p>\n<p><span id=\"ctl00_rpPublication_ctl06_lblPublication\" jquery19104281527696515696=\"525\"><strong>Ruberg FL.<\/strong>\u00a0 T1 mapping in cardiac amyloidosis: can we get there from here? \u00a0<em>JACC Cardiovasc Imaging,<\/em>\u00a06(4):498-500, 2013.\u00a0 <\/span>View in: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23498671\" target=\"_blank\" jquery19104281527696515696=\"527\" rel=\"noopener\">PubMed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, Heneghan MA, Gorevic PD, Litchy WJ, Wiesman JF, Nordh E, Corato M, Lozza A, Cortese A, Robinson-Papp J, Colton T, Rybin DV, Bisbee AB, Ando Y, Ikeda S, Seldin DC, Merlini G, Skinner M, Kelly JW, Dyck PJ.\u00a0 Diflunisal Trial Consortium.\u00a0 Repurposing diflunisal [&hellip;]<\/p>\n","protected":false},"author":8474,"featured_media":0,"parent":662,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/2257"}],"collection":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/users\/8474"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/comments?post=2257"}],"version-history":[{"count":20,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/2257\/revisions"}],"predecessor-version":[{"id":4003,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/2257\/revisions\/4003"}],"up":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/662"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/media?parent=2257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}